A human inhibitor of tumor necrosis factor alpha - PubMed (original) (raw)
A human inhibitor of tumor necrosis factor alpha
P Seckinger et al. J Exp Med. 1988.
Abstract
Urine of some febrile patients exhibits a TNF-alpha inhibitory activity (TNF-alpha INH), sensitive to heat and trypsin, with an apparent mol wt of 40-60 X 10(3) and a pI range of 5.5-6.1. As for the Il-1 INH, the TNF INH activity involves a competitive mechanism of action suggesting the existence of a family of negative feedback-regulating molecules interfering with cytokines actions.
Similar articles
- Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.
Seckinger P, Zhang JH, Hauptmann B, Dayer JM. Seckinger P, et al. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5188-92. doi: 10.1073/pnas.87.13.5188. Proc Natl Acad Sci U S A. 1990. PMID: 2164226 Free PMC article. - Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor.
Seckinger P, Isaaz S, Dayer JM. Seckinger P, et al. J Biol Chem. 1989 Jul 15;264(20):11966-73. J Biol Chem. 1989. PMID: 2545692 - A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.
Seckinger P, Williamson K, Balavoine JF, Mach B, Mazzei G, Shaw A, Dayer JM. Seckinger P, et al. J Immunol. 1987 Sep 1;139(5):1541-5. J Immunol. 1987. PMID: 3040855 - Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities.
Seckinger P, Vey E, Turcatti G, Wingfield P, Dayer JM. Seckinger P, et al. Eur J Immunol. 1990 May;20(5):1167-74. doi: 10.1002/eji.1830200533. Eur J Immunol. 1990. PMID: 2113477 - TNF inhibitor with a low molecular weight found in the human sera.
Shimoda A, Hanaumi K, Kumagai K. Shimoda A, et al. Tohoku J Exp Med. 1995 Dec;177(4):327-35. doi: 10.1620/tjem.177.327. Tohoku J Exp Med. 1995. PMID: 8928192
Cited by
- From supernatants to cytokines: a personal view on the early history of IL-1, IL-1Ra, TNF and its inhibitor in rheumatology.
Dayer JM. Dayer JM. Arthritis Res Ther. 2018 May 30;20(1):101. doi: 10.1186/s13075-018-1607-y. Arthritis Res Ther. 2018. PMID: 29848388 Free PMC article. - Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.
Rider P, Carmi Y, Cohen I. Rider P, et al. Int J Cell Biol. 2016;2016:9259646. doi: 10.1155/2016/9259646. Epub 2016 Dec 19. Int J Cell Biol. 2016. PMID: 28083070 Free PMC article. Review. - Pharmaceutical aspects of anti-inflammatory TNF-blocking drugs.
Jinesh S. Jinesh S. Inflammopharmacology. 2015 Jun;23(2-3):71-7. doi: 10.1007/s10787-015-0229-0. Epub 2015 Feb 17. Inflammopharmacology. 2015. PMID: 25687751 Review. - Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.
Tuttolomondo A, Pecoraro R, Pinto A. Tuttolomondo A, et al. Drug Des Devel Ther. 2014 Nov 7;8:2221-38. doi: 10.2147/DDDT.S67655. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25422582 Free PMC article. Review. - Immune modulation in heart failure: past challenges and future hopes.
Flores-Arredondo JH, García-Rivas G, Torre-Amione G. Flores-Arredondo JH, et al. Curr Heart Fail Rep. 2011 Mar;8(1):28-37. doi: 10.1007/s11897-010-0044-2. Curr Heart Fail Rep. 2011. PMID: 21221862 Review.
References
- Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70 - PubMed
- J Immunol. 1985 Oct;135(4):2492-7 - PubMed
- Nature. 1985 Aug 8-14;316(6028):552-4 - PubMed
- J Exp Med. 1985 Dec 1;162(6):2163-8 - PubMed
- Ann Inst Pasteur Immunol. 1987 May-Jun;138(3):486-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous